Refocusing cancer R&D for greater impact: Addressing gaps in disparities and access

Thyme Care closes $95M Series C to advance optimization of care, navigation

Thyme Care announced the close of a $95 million capital raise. With $55 million in equity funding, Thyme Care welcomes new investor Concord Health Partners with participation from all existing investors, including CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures, and Foresite Capital.

July 19, 2024

Vol.50 No.29

Clinical Roundup

Living in disadvantaged neighborhoods influences stress-related genes, which may contribute to aggressive prostate cancer in African American men

Those living in disadvantaged neighborhoods have significantly higher activity of stress-related genes, research suggests, which could contribute to higher rates of aggressive prostate cancer in African American men.

July 19, 2024

Vol.50 No.29

Clinical Roundup

Cell donor’s socioeconomic status shapes cancer treatment outcomes

The socioeconomic status of cell donors affects the health outcomes of blood cancer patients who underwent hematopoietic cell transplantation, according to a new study led by researchers at the University of Minnesota Medical School.

July 19, 2024

Vol.50 No.29

Conversation with The Cancer Letter

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

What can NCI accomplish in data science?

UAMS receives $1.3M for high school-focused tech and data science exposure program

The University of Arkansas for Medical Sciences has been awarded a $1.3 million grant from NIH for its Arkansas Technology and Data Science in Health and Medicine program.

July 12, 2024

Vol.50 No.28

White House

At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials

Leaders of three health agencies presented new initiatives focused on patient-centered research, diversity in clinical trial enrollment, and innovation in clinical research.

June 28, 2024

Vol.50 No.26

By McKenzie Prillaman

Refocusing cancer R&D for greater impact: Addressing gaps in disparities and access

YOU MAY BE INTERESTED IN

Thyme Care closes $95M Series C to advance optimization of care, navigation

Living in disadvantaged neighborhoods influences stress-related genes, which may contribute to aggressive prostate cancer in African American men

Cell donor’s socioeconomic status shapes cancer treatment outcomes

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

UAMS receives $1.3M for high school-focused tech and data science exposure program

At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials

Renew today!

Subscriber content

Login

Refocusing cancer R&D for greater impact: Addressing gaps in disparities and access

YOU MAY BE INTERESTED IN

Thyme Care closes $95M Series C to advance optimization of care, navigation

Living in disadvantaged neighborhoods influences stress-related genes, which may contribute to aggressive prostate cancer in African American men

Cell donor’s socioeconomic status shapes cancer treatment outcomes

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”“All research now involves data science at some level.”

UAMS receives $1.3M for high school-focused tech and data science exposure program

At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials

Login

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”